Ambu

Transaction in Own Shares • Apr 12, 2016

Buyback programme

On 11 November 2015, Ambu initiated two parallel share buyback programmes for the purpose of hedging share-based incentive programmes.

The share buyback programmes, which run in the period 11 November 2015 and ending on 30 April 2016 at the latest, comprise a total share buyback of DKK 175 million, of which DKK 60 million will be purchased in accordance with the Safe Harbour provisions of European Commission Regulation No. 2273/2003 of 22 December 2003, while the remainder, DKK 115 million, will be purchased in will be purchased in the course of the period, but outside the Safe Harbour rules.

Under the share buyback programmes, the following transactions were conducted in the period 1 to 11 April 2016:

Shares bought under the Safe Harbour rules:

	Number of	Average	Transaction
Date	B shares	market price	value
Accumulated latest announcement	271,307	203.9	55,331,487
1 April 2016	2,500	231.4	578,466
4 April 2016	3,000	232.6	697,915
5 April 2016	3,000	228.9	686,618
6 April 2016	2,000	230.6	461,191
7 April 2016	2,000	230.9	461,772
8 April 2016	2,000	231.8	463,594
11 April 2016	1,500	233.4	350,084
Accumulated under the programme	287,307	205.5	59,031,127

Shares bought outside the Safe Harbour rules:

	Number of	Average	Transaction
Date	B shares	market price	value
Accumulated latest announcement	562,000	204.6	114,968,894
1 April 2016	-	-	-
4 April 2016	-	-	-
5 April 2016	-	-	-
6 April 2016	-	-	-
7 April 2016	-	-	-
8 April 2016	-	-	-
11 April 2016	-	-	-
Accumulated under the programme	562,000	204.6	114,968,894

Following the above transactions, Ambu owns a total of 1,093,207 Class B shares with a nominal value of DKK 2.5 each, corresponding to 2.26% of the share capital. The total number of Class A and Class B shares in the company is 48,352,320 including treasury shares.

Contact

Lars Marcher, President & CEO, tel. +45 5136 2490, email: lm@ambu.com

Ambu A/S Baltorpbakken 13 DK-2750 Ballerup CVR no.: 63 64 49 19 Tel. +45 7225 2000 www.ambu.com

About Ambu

Since 1937, breakthrough ideas have fuelled our work on bringing efficient healthcare solutions to life. This is what we create within our fields of excellence – Anaesthesia, Patient Monitoring & Diagnostics, and Emergency Care. Millions of patients and healthcare professionals worldwide depend on the functionality and performance of our products. We are dedicated to improve patient safety and determined to advance single-use devices. The manifestations of our efforts range from early inventions like the Ambu Bag™ resuscitator and the legendary BlueSensor™ electrodes to our newest landmark solutions like the aScope™ endoscope – the world's first single-use flexible video scope. Our commitment to bringing new ideas and superior service to our customers has made Ambu one of the most recognized medical companies in the world. Headquartered near Copenhagen in Denmark, Ambu employs approximately 2,300 people in Europe, North America and the Asia Pacific. For more information, please visit www.ambu.com.